Fresenius Medical Care showcased latest dialysis products at CIIE

Fresenius Medical Care, one of the world's leading providers of dialysis products and services, showcased its latest innovative products and treatments to visitors at the second China International Import Expo.

At this year's CIIE, Fresenius Medical Care was not only demonstrating its journey, presence and activities in China, but also its research and development capabilities, technologies and renal diseases treatment.

"It's a great honor for us to attend the second CIIE, which is an ideal platform for global healthcare companies like Fresenius Medical Care to showcase our capabilities and efforts in China," said Alan Chen, executive vice-president of Fresenius Medical Care China. "It allows us to demonstrate our strong commitment to supporting the Chinese government in fulfilling the 'Healthy China 2030' vision and to show how we're changing the lives of patients."

Fresenius Medical Care has been providing renal care for patients in China since 1990.

In recent years, Fresenius Medical Care has significantly expanded its product base and dialysis services in China. China is Fresenius Medical Care's second-largest product market globally.

To Fresenius Medical Care, innovation is one of the key strategies in China, which allows the company to address patients' needs in the country more effectively.

In 2015, the company expanded its R&D activities in China with the establishment of the China Design Center in Shanghai. The center works with the production site in Changshu, Jiangsu province and collaborates with the R&D team in Schweinfurt, Germany.

"It is important to enhance the accessibility and affordability of dialysis in primary care, especially in the rural regions of China," Chen said.

"Recently, the Chinese government has been encouraging the expansion of quality medical resources into rural areas, to improve primary healthcare in these areas. With our expertise, innovation and knowledge, we can support China's overarching vision and bring hope to patients and their families."

"Technology can make a huge difference in patients' lives," he added.

"At Fresenius Medical Care, we want to provide products and kidney care services while continuing to pursue innovation."

Highly trained healthcare professionals are critical to providing quality care. For this reason, the company has been working with local medical associations to offer continuous educational support to local healthcare professionals.

Through its dialysis training center in Shanghai, Fresenius Medical Care shares expertise and knowledge with nurses and doctors across the country. Thanks to the trust and support of the national and provincial governments, healthcare professionals and its partners, Fresenius Medical Care said it has achieved a leading position in China, with a growing reach for its products and an increasing number of patients.

In order to contribute more to communities, the company is committed to educating the public about good kidney health, with an overall aim of preventing chronic kidney disease.

In 2018, Fresenius Medical Care launched its "Back to the Wall - Ignite Hope of Life" campaign, supporting extreme adventurers and philanthropists David Grier and Andrew Stuart in completing the challenge of their 4,200-kilometer run along the Great Wall in just 70 days.

The campaign aimed to raise awareness of good kidney health in China while encouraging patients with chronic kidney disease to live their lives to the fullest.

Along the course of the runners' journey, a series of local running events joined by doctors, nurses and patients was also held across China, including in Beijing, Yulin, Kunming, Jiayuguan, Dongguan and Hangzhou.

To continue to increase public awareness of kidney health in China, the "Fresenius Medical Care Hope Igniting Day" takes place across the country on July 3 every year.

(China Daily 11/13/2019 page15)